Treatment effectiveness with venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An international real-world study Meeting Abstract


Authors: Ghosh, N.; Lamanna, N.; Eyre, T. A.; Coombs, C. C.; Manzoor, B. S.; Brown, J. R.; Tuncer, H. H.; Ujjani, C. S.; Leslie, L. A.; Roeker, L. E.; Davids, M. S.; Rhodes, J. M.; Skarbnik, A.; Emechebe, N.; Fleury, I.; Hill, B. T.; Fox, C. P.; Barr, P. M.; Jawaid, D.; Sinai, W. J.; Pearson, L. K.; Lansigan, F.; Choi, Y.; Jensen, C. E.; Schuster, S. J.; Kennard, K.; Pivneva, I.; Watson, T.; Guerin, A.; Shadman, M.
Abstract Title: Treatment effectiveness with venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An international real-world study
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 1908
Language: English
ACCESSION: WOS:001159306707135
DOI: 10.1182/blood-2023-179198
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lindsey Elizabeth Roeker
    143 Roeker